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9 ABSTRACT: Lipid-binding proteins (LBPs) are soluble proteins responsible for the uptake, transport, and storage of a large
10 variety of hydrophobic lipophilic molecules including fatty acids, steroids, and other lipids in the cellular environment. Among
11 the LBPs, fatty acid binding proteins (FABPs) present preferential binding affinities for long-chain fatty acids. While most of
12 FABPs in vertebrates and invertebrates present similar β-barrel structures with ligands accommodated in their central cavity,
13 parasitic nematode worms exhibit additional unusual α-helix rich fatty acid- and retinol-binding proteins (FAR). Herein, we
14 report the comparison of extended molecular dynamics (MD) simulations performed on the ligand-free and palmitic acid-bond
15 states of the Necator americanus FAR-1 (Na-FAR-1) with respect to other classical β-barrel FABPs. Principal component
16 analysis (PCA) has been used to identify the different conformations adopted by each system during MD simulations. The α-
17 helix fold encompasses a complex internal ligand-binding cavity with a remarkable conformational plasticity that allows
18 reversible switching between distinct states in the holo-Na-FAR-1. The cavity can change up to one-third of its size affected by
19 conformational changes of the protein−ligand complex. Besides, the ligand inside the cavity is not fixed but experiences large
20 conformational changes between bent and stretched conformations. These changes in the ligand conformation follow changes
21 in the cavity size dictated by the transient protein conformation. On the contrary, protein−ligand complex in β-barrel FABPs
22 fluctuates around a unique conformation. The significantly more flexible holo-Na-FAR-1 ligand-cavity explains its larger ligand
23 multiplicity respect to β-barrel FABPs.
1. INTRODUCTION
24 Hydrophobic lipophilic molecules like fatty acids, steroids,
25 retinoids, and their derivatives participate in a large variety of
26 functions within a cell, including energy storage, signaling,
27 regulation of gene expression, hormonal roles, and membrane
28 permeability regulation among others. Their insolubility in
29 water and their potential oxidative degradation require their
30 coordinated transport and availability, protection and regu-
31 lation throughout the hydrophilic intracellular environment.
32 Soluble lipid-binding proteins (LBPs) are a group of abundant
33 proteins that are responsible for these tasks throughout the
34 aqueous environment inside numerous types of cells1 and body
35 fluids of different organisms.2 Helminth parasites have a
36 restricted lipid metabolism and must acquire simple and
37 complex lipids from their hosts,3 therefore LBPs probably
38perform very important functions for parasite growth and
39development.
40Fatty acid and retinol binding proteins (FARs) are LBPs that
41have been described as components of E/S fluids from
42parasitic nematodes4−7 and they are hypothesized to play
43essential roles in lipid acquisition and distribution of nutrients
44as well as potential dampening of host’s immune response.8,9
45FARs together with nematode polyprotein/allergens (NPAs)10
46are small (14−20 kDa), helix rich proteins that bind retinol
47and fatty acids and have no recognizable counterparts in other
48animal groups.2 Given these characteristics, FARs have been
49proven to be useful for serodiagnosis and experimental
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50 vaccines.11−13 Moreover, there is evidence that FARs from
51 filarial nematodes are able to bind anthelmintic drugs.14,15
52 Hookworm disease is a highly debilitating helminth infection
53 that is related to iron deficiency anemia (IDA) in tropical
54 developing countries with an estimated prevalence of 451
55 million cases that cause 1.6 million years lived with disability
56 (YLD).16 Necator americanus, together with Ancylostoma
57 duodenale and Ancylostoma ceylanicum, are the causative agents
58 for the above mention “hookworm disease”. It is important to
59 note that N. americanus is responsible for the majority of cases
60 worldwide. This parasitosis has been successfully eradicated
61 from developed countries by mass drug treatments and by
62 economic development.17 Nevertheless the levels of disease
63 burden remains high in many low middle income countries like
64 the north region of Argentina.18
65 FARs occur in several isoforms, and Na-FAR-1 has been
66 found to be highly expressed in the adult form.19,20 At the
67 present time, two orthologues FAR structures were solved, one
68 from Necator americanus (Na-FAR-1 by protein nuclear
69 magnetic resonance (NMR) and X-ray crystallography; PDB:
70 4UET and 4XCP, respectively)20 and another from Caeno-
71 rhabditis elegans (Ce-FAR-7, by X-ray crystallography; PDB:
72 2W9Y).21 Both present similar overall α helix-rich structures
73 with certain structural differences. Particularly, the size and
74 shape of their internal cavities are different, denoting
75 differences in their ligand selectivity. Na-FAR-1, in either its
76 apo- and holo-conformations, presents a larger and more
77 complex internal ligand-binding cavity.20
78 Among soluble LBPs, another interesting group is the fatty
79 acid binding proteins (FABPs) family presenting preferential
80 binding affinities for long-chain fatty acids.22−27 While FARs
81 have been found exclusively in nematodes28 FABPs can be
82 found in vertebrates and invertebrates. Despite their low
83 sequence identity and their functional divergence, probably
84 related to their particular lipid-binding preferences, they share
85 a common tertiary structure.29,30 They all have similar β-barrel
86 structures that encase the bound fatty acid. The volume of the
87 inner ligand-binding cavity is determined by the side chains of
88 the residues that define the molecular surface enclosing it.
89 These residues vary between the different FABP types, and
90 they determine the ligand specificity of the cavity. Various
91 single point mutations, performed on residues lining the cavity
92 of different FABP types, have shown to modify the protein
93 conformational stability, ligand specificity and affinity.31−36
94 Several studies, based on crystal and solution analysis,
95 predicted the way FAs enter and leave the FABP binding
96 site;24,37 this is fundamental to understanding the molecular
97 mechanism of ligand selection and delivery in FABPs.38,26,39−42
98 These works have shown the importance of certain residues
99 and domains in the protein dynamics, confirming observations
100 performed by different experimental methods and allow to
101 hypothesize about these protein’s proposed functions in the
102 cell. While nematodes also produce β-barrel FABPs, the
103 reasons why nematodes have specialized in the use of α-helix
104 rich proteins remain unclear.
105 An understanding of how the conformational diversity of
106 FARs contributes to their ligand multiplicity, varying the
107 relative affinities for different hydrophobic lipophilic mole-
108 cules, could enlighten their roles in parasitism and suggest
109 possible targets for therapeutic interventions. Fluorescence-
110 based ligand-binding assays and titration of Na-FAR-1 with
111 sodium oleate monitored by NMR reveal its high ligand
112 multiplicity.20 These studies suggest the higher propensity of
113the α-helical fold to bind a larger variety and quantity of FAs
114and other lipid classes than the β-barrel fold. Besides, Na-FAR-
1151 ligand-binding induces substantial chemical shift changes for
116residues throughout the protein, indicating significant con-
117formational changes that allow the structure to expand.
118Molecular dynamics (MD) simulations43−46 combined with
119principal component analysis (PCA)47−51 provide a framework
120for decomposing the complexity of proteins motions into
121decoupled individual contributions. PCA is a useful multi-
122variate statistical method that has been applied to reduce the
123number of dimensions needed to describe protein dynamics.
124This combination of MD and PCA has recently been applied
125to develop a procedure that reveals the existence of
126correlations between the dynamics of cavities and struc-
127tures.52,53 Besides, MD simulations have shown to be the
128adequate computation method to reveal several dynamic and
129functional aspects of LBPs,54,55,40,56 like ligand entry and leave
130pathways and complex formation,26,39,57 and binding-relevant
131intermediate states.42 Moreover, MD simulation of the
132flexibility of the internal cavity has shown to be a requirement
133for a good simulation of ligand-LBPs affinities.58
134Herein we explore the structure-dynamics-function relation-
135ship of Na-FAR-1 using long molecular dynamics simulations
136combined with PCA in its apo- and holo-forms. We analyze its
137plasticity and the impact of the different conformations on the
138ligand-binding cavity volume. We were focused on the
139dynamics relationships between protein fluctuations, cavity
140changes, and the enclosed ligand different conformations. A
141comparison of our results with those obtained from MD
142simulations of the rat intestinal fatty-acid-binding protein (I-
143FABP) with the typical FABP β-barrel fold, and the orthologue
144Ce-FAR-7 is performed. Our analysis reveals that Na-FAR-1
145encompasses a complex internal ligand-binding cavity with a
146remarkable conformational plasticity that allows reversible
147switching between distinct states according with the enclosed
148ligand different conformations.
2. METHODS
1492.1. Molecular Dynamics simulations. Molecular
150dynamics (MD) simulations were performed for Na-FAR-1
151and I-FABP, both in their apo- and holo- forms with palmitate
152in their binding pockets, and Ce-FAR-7 in its unligated form.
153These were carried out with AMBER 16 software package,.59,60
154Initial structures for each protein were obtained from the
155protein data bank61 (pdb id 4UET (no. of atoms = 23173) and
1564XCP (no. of atoms= 22707) for apo- and holo-Na-FAR-120
157respectively, 1IFB62 (no. of atoms = 15502) for apo-I-FABP,
1582IFB63 (np. of atoms = 15768) and 1URE64 (no. of atoms =
15916143) for holo-I-FABPs and 2W9Y21 (no. of atoms 21528)
160for apo- Ce-FAR-7). Each protein was solvated with explicit
161water molecules in a rectangular periodic box large enough to
162contain the protein and 10 Å of solvent on all sides. Ions are
163added for charge neutralization. Periodic boundary conditions
164and particle-mesh Ewald (PME) sums were applied. The
165AMBER ff14SB65,66 force field and the TIP3P67 water model
166were used in all simulations. Minimization of each system was
167performed in two steps: first, constraints were applied to the
168protein atoms and 200-steps of steepest-descent and 800-steps
169of conjugate gradient minimization were run; then, constraints
170are lifted and the same procedure were applied again. This was
171followed by 400 ps of heating to reach the final temperature of
172300 K. During heating a harmonic constraint of 25.0 (kcal/
173mol)/Å2 was applied to the protein atoms. The time step was 2
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174 fs, and the SHAKE algorithm was employed to constrain bonds
175 involving hydrogen atoms. A cutoff of 10 Å was applied to
176 nonbonded interactions. Systems were equilibrated for 7.8 ns
177 at constant pressure gradually reducing the constraints every
178 100 ps until all restraints were lifted. After that, the systems
179 were equilibrated at the constant temperature of 300 K using
180 the Andersen barostat and the Langevin thermostat with a γ
181 collision frequency of 2 ps−1 during 12.2 ns. Finally, 3-μs
182 production MD runs were performed, during which config-
183 urations were collected at 10 ps intervals.
184 2.2. Principal Component Analysis. PCA is an
185 extensively used statistical procedure to identify the essential
186 dynamics from MD simulations47−51,68 and, thereby, facilitate
187 the study of long time dynamics. For the sake of consistency,
188 we briefly review PCA below.
189 Herein, PCA modes Qi are 3N orthogonal eigenvectors
190 obtained as columns of the eigenvector matrix L, that results
191 after diagonalizing (LTCL = Λ) the covariance matrix of
192 atomic fluctuations C whose elements are defined as
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196 is the mass-weighted internal displacement of Cartesian
197 coordinate xi
k of the ith atom (i = 1, ..., N; N = number of
198 residues in the protein (Cα) with mass mi, and the angular
199 brackets represent the average obtained from the K
200 configurations.68 The elements of the diagonal matrix Λ
201 represent the relative contribution of each PCA or essential
202 mode (EM) to the overall fluctuation of the molecule. The
203 eigenvectors are typically ordered according to descending
204 eigenvalues, with the first PCA mode being the one with major
205 contribution.
206 2.3. Ligand-Cavities: Definition, Volume, and Flexi-
207 bility. Ligand-cavities have been defined by visual inspection
208 of the average of equilibrated MD structures and previous
209knowledge on each system. The complete list of residues lining
210the main ligand-binding cavity for each system is provided in
211the Supporting Information (Table S1).
212Cavity volumes are calculated using our previously
213developed method,53 particularly suited to measure changes
214in cavity volumes due to small atomic coordinate displace-
215ments in the direction of specific predefined directions of
216protein structural displacements. Following our previous works
217we make use of the volume gradient vector (∇Vol), defined as
218the vector of partial derivatives of the cavity volume in the
219basis of PCA modes {Qi}i=1,3N, that is



















221Within the frame of the quasi-harmonic analysis approx-
222imation,69 the variation of the potential energy of a protein in




















B , kB the Boltzmann constant and T the absolute
228temperature (300 K). ΔX represents a relative displacement in
229the direction of ∇Vol. Therefore, we consider ΔE∇Vol as
230measure of flexibility of the cavities.
3. RESULTS AND DISCUSSION
2313.1. α-Helix Rich FARs. While most of FABPs present a β-
232barrel folding, FARs reveals an unusual α-helical fold. In the
233case of Na-FAR-1, it consists of a wedge-shaped structure
234composed of 11 helices with different lengths that enclose an
235internal ligand-binding cavity. The overall ligand-binding
236conformational change involve a global RMSD of 0.98 Å
Figure 1. Averaged (b) apo- and (d) holo-structures for Na-FAR-1 obtained from the corresponding equilibrated MD simulations, indicating the
main secondary structure elements (SSE) and the encompassed ligand cavity. Distribution of ligand cavity volumes, calculated over the set of
structures collected during the equilibrated MD simulations of (a) apo- and (c) holo-Na-FAR-1.
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237 between conformers, calculated from the α-carbons super-
238 position of averaged apo- and holo-structures obtained from the
f1 239 corresponding equilibrated MD simulations (see Figure 1b,d).
240 Both holo-states for Na-FAR-1 and I-FABP are bound to a
241 single molecule of palmitate. It is important to note that this is
242 the preferred ligand of Na-FAR-1 in a biological environment20
243 The main structural distortions upon ligand binding are
244 localized on helices 310, α2, α7, α10 and the loops between 310-
245 α2, α2-α3, α4-α5, and α7-α8. Among these Secondary
246 Structure Elements (SSE), α4-α5 and α7-α8 have shown the
247 largest root-mean-square fluctuations (RMSF; see Figure S1)
248 during our MD simulations, particularly residues 39−45 in α4-
249 α5 loop and residues 100−103 in α7-α8 loop present the
250 largest relative flexibility. The structural change of α4-α5 loop
251 during ligand-binding is expected since this loop is part of the
252 single opening of the ligand-binding cavity, located between
253 this loop and helices α6 and α7. Besides this opening, α7-α8
254 loop has been previously proposed20 as the main candidate to
255 participate of the ligand entrance through the portion of the
256 cavity accessible to solvent.
257 At this point it is interesting to note that the RMSD between
258 average holo- and apo- structures of Na-FAR-1 is only 1.58 Å.
259 Nevertheless, in a previous article,70 we have pointed out that
260 small structural distortions can involve large changes in the
261 cavities of the proteins. Besides, in cases that proteins explore
262 multiple conformers during MD simulations, the average
263 structural is not a good statistics. Therefore, in what follows,
264 the identification of different conformers and their impact on
265 the ligand-cavity is discussed.
266 A further inspection of the internal ligand-binding cavity can
267 be seen in Figure 1a,c where the distributions of cavity
268 volumes, calculated over the set of structures collected during
269 the equilibrated MD simulations of apo- and holo-Na-FAR-1,
270 are shown. Their average values are 1353 ± 254 and 1397 ±
271 266 Å3 respectively. These values differ from the corresponding
272 940 and 2170 Å3 calculated on the initial experimental
273 structures.20 As we have pointed out previously, we define
274 internal cavities according to average structures obtained from
275 our MD simulations. The distributions shown in Figure 1a,c
276 are the result of the protein thermal fluctuations that can
277 involve different conformational changes throughout the 3-μs
278 of MD simulations. Fluctuations of helices that form the cavity
279 introduce relatively small protein structural rearrangements
280 that can lead to significant changes on the internal cavity size.70
281 Histograms shown in Figure 1a,c reveal that internal cavity can
282 duplicate its volume due to protein fluctuations. While the
283 distribution of volume cavities for apo-Na-FAR-1 corresponds
284 to a Gaussian distribution that can be associated with thermal
285 fluctuations around a unique protein conformation, this is not
286 the case for holo-Na-FAR-1.
287 Volume cavity changes can be associated with protein
288 fluctuations. Therefore, in order to elucidate this feature, MD
289 simulations were analyzed in terms of PCA. The first and
290 second PCA modes of apo- and holo-Na-FAR-1are shown in
f2 291 Figure 2a,b. In both conformers, the first 2 modes involve the
292 concerted motion of residues located in helices α4, α5, the
293 loop between, and the C-term of the helix α7. In agreement
294 with previous experimental observations,20 the last helix has
295 the most impact on cavity volume, while the former form the
296 ligand entrance gate (α4-α5 gate).
f3 297 Figure 3a,b show the projection of the set of MD snapshots
298 of apo- and holo-Na-FAR-1 onto their corresponding first and
299 second PCA modes. Thermal fluctuations of apo-Na-FAR-1 are
300revealed as gradual combinations of both modes without
301showing significant prevalence of structural distortions in any
302specific direction. That is, apo-Na-FAR-1 does not visit any
303new conformation that persists a significant amount of time
304during the MD simulation. On the contrary, we can observe
305that holo-Na-FAR-1 actually evidence the existence of three
306different conformers: two stable conformers presenting
307structural distortions mainly in both senses of the direction
308of the first PCA mode (conformers A and B), and a third
309conformer C in the direction of the second PCA mode. The
310projections of the set of MD snapshots of apo- and holo-Na-
311FAR-1 onto their corresponding third PCA modes do not
312show the existence of new stable conformers with structural
313distortions in the direction of these modes (see Figure S2).
314The major differences among conformers A, B, and C lie in the
315α4-α5 gate and the helix α7. Conformer A’s α7 helix is
316relatively straightened, allowing the α4-α5 gate to close up. B’s
317α7 helix has a kink next to its C-term around ILE 104, which
318displaces the α4-α5 gate. This kink is even steeper in
319Conformer C. This kink is the main reason for the volume
320 f4decrease in conformers B and C (see Figure 4a). Therefore,
321the distribution of internal cavity volumes shown in Figure 1c
322can be interpreted as the contribution of three different
323conformations explored by holo-Na-FAR-1 during the MD
Figure 2. 1st (red) and 2nd (blue) PCA modes of (a) apo- and (b)
holo-Na-FAR-1.
Figure 3. Contour density plots of the projection of the set of MD
snapshots of (a) apo- and (b) holo-Na-FAR-1 onto their
corresponding 1st and 2nd PCA modes.
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324 simulation. Figure 4b shows the distribution of cavity volumes
325 for each of them. While two of the holo-Na-FAR-1conformers
326 (B and C) enclose relative small internal cavities with average
327 volumes of 1130 ± 126 and 1211 ± 150 Å3, the other
328 conformer (A) presents a large cavity of 1568 ± 222 Å3. These
329 results indicate that holo-Na-FAR-1 presents a remarkable
330 conformational plasticity that drives a complex internal cavity
331 dynamics. The three identified conformers are in dynamical
332 equilibrium connected by conformational changes involving
333 the first and the second PCA modes. Figure 4c shows the
334 evolution in time of the cavity volume displaying the different
335 contributions of each of the three conformers. Reversible
336 interconversions between them can be observed during the
337 MD simulation. These results are in complete agreement with
338 our previous analysis of the apo and holo structures of Na-FAR-
339 1 employing NMR spectroscopy.20 In the referred work, NMR
340 spectra of holo-Na-FAR-1 in solution, like those of other FAR
341 proteins previously tested, were characterized by broad signal
342 peaks indicative of multiple conformations and/or conforma-
343 tional exchange. However, apo-Na-FAR-1gave good solution
344 NMR spectra which allowed the structure of apo-Na-FAR-1 to
345 be determined. In the same work the ligand binding process
346 was followed through NMR and showed that the protein
347 exhibited slow exchange behavior through the addition of 1, 2,
348 and 3 mol equiv of the ligand (oleate), which would suggest
349 that the protein binds three ligands with high affinity. The
350 higher plasticity of the protein after the incorporation of one
351 molecule of ligand, as shown in the present work, would
352eventually make the protein more susceptible to accept more
353ligand molecules.
354In order to further understand the effect of higher
355conformational plasticity of holo-Na-FAR-1 respect to apo-
356Na-FAR-1 on the ligand binding, the dynamics of the ligand
357within the cavity has been explored. For this purpose, ligand
358 f5structural fluctuations have been analyzed using PCA. Figure
359 f55(a) shows the projection of the ligand structures, obtained
360throughout the MD simulation, onto its first and second PCA
361modes. Two distinctive ligand conformations represented by
362the structural distortions in both senses of the direction of the
363first PCA mode can be observed. They correspond to the bent
364and stretched conformations shown in Figure 5a. As can be
365seen in Figure 5b, the ligand fluctuates between them, being
366the stretched conformation associated with large cavity
367volumes while the bent one is observed within smaller cavity
368volumes (Figure 5c). That is, far from being fixed within the
369cavity, the ligand experiences large conformational changes
370associated with changes of cavity volume.
371The relationship between the different holo-Na-FAR-1
372conformers, with their corresponding associated changes in
373the internal cavity volume, and the different ligand
374conformations can be analyzed by depicting the distribution
375of distances between the extremes of the palmitate molecule,
376that is, the distance from the C atom of carboxyl group to the
377 f6C atom of the methyl group (see Figure 6). We can observe
378that the stretched palmitate conformation is associated with
379the holo-Na-FAR-1 conformer (A) with the largest internal
380cavity and the straightened α7 helix to make room for the
Figure 4. (a) Superposition of the three conformers (A, B, and C) of
holo-Na-FAR-1; (b) distribution of cavity volumes for each of the
conformers (A, B, and C) of holo-Na-FAR-1 during the MD
simulation; (c) evolution in time of the cavity volume displaying
the different contributions of each of the three A, B, and C
conformers.
Figure 5. (a) Contour density plots of the projection of the palmitate
structures, obtained from the set of MD snapshots of holo-Na-FAR-1,
onto its 1st and 2nd PCA modes; (b) distribution of cavity volumes
according to the conformation of the ligand encompassed in it; (c)
evolution in time of the cavity volume displaying the different
conformations adopted by the ligand.
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381 ligand, while the bent conformation is mainly present on the
382 other two conformers (B and C). Since the three holo-Na-
383 FAR-1 conformers are in dynamics equilibrium during the MD
384 simulation (see Figure 4c), the ligand changes its conformation
385 accordingly to the corresponding changes in the cavity sizes
386 associated with each protein conformational change.
387 Finally, MD simulations have been performed on the
f7 388 orthologue Ce-FAR-7 in its apo-conformation. Figure 7b
389 shows the average structure obtained from the corresponding
390 equilibrated MD simulation. Ce-FAR-7 is an orthologue of Na-
391 FAR-1 that, despite its similar overall fold, it presents an
392 internal cavity different in size and shape respect to Na-FAR-
393 1.20 Therefore, a comparison of the relative flexibility of the
394 ligand-binding cavities for Ce-FAR-7 and Na-FAR-1 can
395 enlighten on the origin of the differences in their ligand
396 binding and biological properties.
397 The RMSD between average apo-Na-FAR-1 and apo-Ce-
398 FAR-7 is 2.77 Å. In agreement with apo-Na-FAR-1, Figure 7a
399 shows that the distribution of its internal cavity volume can be
400 associated with protein fluctuations around a unique
401 conformation characterized by a free energy landscape with a
402 relatively deep well. These results are in agreement with the
403 observations made by Rey-Burusco et al.20 where the estimated
404 cavity for Ce-FAR-7 calculated revealed a much smaller size
405 than for both forms of Na-FAR-1.
406 3.2. β-Barrel FABPs. While FARs exhibit α-helix rich folds,
407 most FABPs present a typical FABP β-barrel fold that includes
408 a small and displaced hydrophobic core and a cavity filled with
409 water molecules. In order to understand how the different folds
410 impact on the protein properties associated with the transport
411 of a variety of ligands with different shapes and sizes, MD
412 simulations have been performed on the rat intestinal fatty-
413 acid-binding protein (I-FABP) in its holo and apo forms. The
414 ligand-binding conformational change involves a structural
415distortion with a RMSD = 1.00 Å. The average internal ligand-
416cavity is significantly smaller than Na-FAR-1, being 605 ± 145
417and 926 ± 85 Å3 for apo-I-FABP and holo I-FABP respectively
418 f8(see Figure 8). We can observe that the distribution of cavity
419volumes for apo-I-FABP can be associated with the
420contribution of different conformations explored during the
421MD simulation. On the contrary, ligand-binding funnels holo-I-
422FABP onto a unique rigid state. These results are in good
423agreement with previous NMR measurements performed on
424human L-FABP71 and rat I-FABP72 that describe ligand
425binding as a transition of the protein structure from a slightly
426more disordered and flexible apo-state to a more ordered holo-
427state. Additionally, limited proteolysis experiments performed
428on apo- and holo- rat IFABP showed that the holo-form was
429resistant to overnight treatment while apo-IFABP was fully
430degraded.73,74 This analysis have also been applied on cestodes
431FABPs yielding the same result.75 Besides, the comparison of
432RMSF obtained during our MD simulations indicates larger
433fluctuations for the apo- than for the holo- I-FABP (see Figure
434S1). This is in good agreement with the results of Matsuoka et
435al.40 where the authors show that the calculated RMSF values
436were less than 1.0 Å for almost all protein residues, indicating
437that this protein is rigid in the ligand-bound form. This
438increased mobility and discrete disorder in the apo-state may
439facilitate the entry of the ligand into the cavity.
440PCA allows the identification of the different apo-I-FABP
441conformers and their corresponding effect on the volume of
442 f9the internal cavity (see Figure 9a,b). Four different conformers,
443associated with different combinations of structural distortions
444in the directions of the first and second PCA modes, have been
445identified (see also Figure S3 and Figure S4). Two of them (A
446and B) are associated with smaller cavity volumes than the
447other two(C and D). Figures 9c shows that apo-I-FABP
448experiences multiple conformational changes throughout the
449MD simulation, indicating a relatively low energy barrier
450between its states. On the contrary, the projection of the set of
451MD snapshots of holo-I-FABP onto its first and second PCA
452modes does not reveal the existence of multiple conformers
453but rather a unique rigid state (see Figure S5). This is in
454agreement with the distribution of its cavity volumes, shown in
455Figure 8c, represented as a Gaussian distribution that can be
456associated with fluctuations around a unique minimum in the
457protein conformational space. Ligand binding seems to shift
458the conformational equilibrium of I-FABP to a unique
459conformation with a sufficiently deep well to ensure that a
460significant fraction of protein molecules are trapped fluctuating
461in it.
4623.3. Relative Flexibility of the Ligand-Cavities. The
463different FARs and FABPs analyzed in this study have shown
Figure 6. Distribution of distances between the extremes of the
palmitate molecule for each of the conformers (A, B, and C) of holo-
Na-FAR-1 during the MD simulation.
Figure 7. (a) Distribution of its internal cavity volume, calculated over the set of collected MD structures. (b) Averaged structure of apo-Ce-FAR-7
obtained from the equilibrated MD simulation.
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464 ligand-cavities with different shapes whose dynamics is subject
465 to the corresponding protein plasticity. In order to analyze
466 which LBP fold encompasses a more flexible cavity and,
467 therefore, a cavity that can contribute to a larger ligand
468 multiplicity, we calculated the variation of the potential energy
469 of each LBP in the direction of ∇Vo (see section 2.3). Results
f10 470 are shown in Figure 10a. We consider the amplitude of the
471 displacement in the direction of ∇Vo achieved with an energy
472 equal to kT = 0.593 kcal/mol (with k being the Boltzman’s
473 constant and T = 298 K) as a measure of flexibility of the
474 cavity.53 We can observe that the internal cavity of apo-I-FABP
475 results the most flexible one, followed by holo- and apo-Na-
476 FAR-1. Apo-Ce-FAR-7 presents a relatively more rigid cavity.
477 Besides, the two holo-I-FABPs (1URE and 2IFB) enclose the
478 most rigid cavities, reinforcing the idea that β-barrel I-FABPs
479 follow a ligand-binding strategy involving a holo-state with
480 restricted motional freedom.
481 While both holo-Na-FAR-1 and apo-I-FABP encompass
482 cavities with different sizes according to the transient protein
483 conformation, Figure 10b,c displays the analysis of the
484 corresponding individual conformers. We can observe that,
485 in both cases, each conformer result relatively more rigid than
486 the average shown in Figure 10a, indicating that their
487 individual contributions introduce an additional component
488 to the overall flexibility of the cavity. Furthermore, holo-Na-
489 FAR-1 conformers are less rigid than the average (see Figure
490 10b) compared to apo-I-FABP conformers relative to their
491 corresponding average (see Figure 10c). That is, the flexibility
492 of holo-Na-FAR-1 seems to be more uniformly distributed
493 among the conformer populations in dynamic equilibrium.
494 Therefore, we conclude that the native state of I-FABP, defined
495 as an equilibrium of pre-existing populations of states, can be
496 considered in general more flexible than the native state of I-
497 FABP. These results indicate a propensity of Na-FAR-1 to bind
498 not only fatty acids but also a broader range of lipid classes
499 such as retinol and phospholipids. This feature is in agreement
500 with previous fluorescence experiments performed on Na-
501 FAR-1 and Ce-FAR-7.20
4. CONCLUSIONS
502Parasitic helminths produce and release an unexpectedly wide
503range of LBPs that are structurally distinct from those of their
504hosts. Although poorly understood, helminth LBPs are often
505immunodominant in infection. Some of them attract allergic-
506type antibody responses and have been associated with
507protective immunity.4,76−78 The evolutionary reasons why a
508single species expresses different types of LBPs remain unclear.
509FARs are commonly found in the secretions of parasitic
510nematodes, possibly indicating their role in parasitism.
511Parasites need to acquire nutrients from their hosts and they
512also need to defend themselves against immune response from
513the host. In this sense, it is hypothesized that they interfere by
514sequestering signaling lipids produced by the host. Therefore, a
515large ligand multiplicity of FARs would help in both lipid
516acquisition and sequestering. As mentioned before they have
517also been proven as good vaccine candidates.13
518Protein fluctuations−cavity changes relationships have been
519explored on different α-helix rich FARs and β-barrel FABPs
520using long equilibrated MD simulations of either apo- and holo-
521states. We found a significantly flexible Na-FAR-1 ligand-cavity
522that can explain the observed larger ligand multiplicity of α-
523helix FARs respect to β-barrel FABPs. The comparison of the
524relative flexibility of ligand-binding cavities of Ce-FAR-7 and
525Na-FAR-1 reveals how a similar fold can enclose internal
526cavities with significant differences in their flexibilities and
527dynamics. These differences can explain differences in their
528ligand multiplicity and, therefore, their biological function.
529Moreover, differences in ligand binding capacities have been
530observed between two isoforms from the same species.13
531We have reported two different ligand-binding strategies.
532Particularly, holo-Na-FAR-1 presents a remarkable conforma-
533tional plasticity that drives a complex internal cavity dynamics
534involving different states. The size of the cavity is significantly
535affected by protein conformational changes. Besides, the ligand
536also changes its conformation according to these conforma-
537tional changes. That is, far from being fixed within the cavity,
Figure 8. Distribution of ligand cavity volumes, calculated over the set of structures collected during the equilibrated MD simulations of (a) apo-
and (c) holo- I-FABP. Averaged (b) apo- and (d) holo-structures for I-FABP obtained from the corresponding equilibrated MD simulations,
indicating the main secondary structure elements (SSE) and the encompass ligand cavity.
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538 the ligand experiences large conformational changes between a
539 bent and stretch conformation. The ligand conformation
540 changes according to the size of the cavity that is dictated by
541 the transient protein conformation. On the contrary, ligand
542 binding in I-FABPs seems to shift the conformational
543 equilibrium to a unique conformation. In this way, α-helix
544 FARs and β-barrel FABPs seem to follow two different
545 strategies for ligand-binding. FARs involve a holo-state with
546 high plasticity; they experience conformational changes that
547 significantly impact on the cavity volume and embedded ligand
548 conformations. On the other hand, FABPs experience an
549 inverse ligand-modulated disorder−order transition leading to
550 a holo-state with restricted motional freedom. This piece of
551 information could give light on the biological reasons for the
552 existence of different LBPs types in the same organism.
553 Human hookworm infections represent a significant
554 problem in South America. There is an urgent need to design
555 new treatments based on the knowledge of the metabolism of
556 the parasites. Na-FAR1 has shown to be part of the excretion/
557 secretion products, playing an important role in the host-
558 parasite relationship. It may participate in the acquisition of
559 lipids from the host or sequestering signaling molecules
560 dampening the immune response from the host. The detailed
561 knowledge of the structural and dynamics properties of its
562ligand-binding cavity could contribute to the design of new and
563more specific inhibitors. The flexibility of protein cavities
564impacts on functional aspects like ligand affinities and binding
565promiscuities. The present work can encourage the develop-
566ment of drugs that rigidize the cavity of Na-FAR-1, reducing its
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573Table S1: List of residues lining the main ligand-binding
574cavity for each system. Residues are numbered according
575to their order in the corresponded PDB file. Figure S1:
576Root mean square fluctuations (RMSF) during our MD
577simulations. Figure S2: Histogram of the projection of
578the set of MD snapshots of holo-I-FABP onto its third
579PCA mode. Figure S3: First (red) and second (blue)
580PCA modes of (a) apo- and (b) holo-I-FABP. Figure S4:
581Superposition of the four conformers (A, B, C, and D)
582of apo-I-FABP. Figure S5: Contour density plots of the
583projection of the set of MD snapshots of holo-I-FABP
584onto their corresponding first and second PCA modes
585(PDF)
Figure 9. (a) Contour density plots of the projection of the set of MD
snapshots of apo-I-FABP onto its 1st and 2nd PCA modes; (b)
distribution of cavity volumes for each of the apo-I-FABP conformers
(A, B, C, and D) during the MD simulation; (c) evolution in time of
the cavity volume displaying the different contributions of each of the
four conformers A, B, C, and D conformers.
Figure 10. Potential energy change in the direction of ∇Vol for each
(a) protein structure, (b) holo-Na-FAR-1 conformer, and (c) apo-I-
FABP conformer. The black line indicated as kT= 0.593 kcal/mol
(with k being the Boltzman’s constant and T = 298 K) has been
added as reference of the average energy per degree of freedom at
room temperature.
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